Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
April 05, 2023 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
InnerScope Hearing Technologies (OTC: INND) Announces New Internal Hearing Aid Sales & Hearing Care Professional Call Center
February 23, 2022 08:00 ET
|
InnerScope Hearing Technologies, Inc.
Staffed by a Highly Experienced Team of Licensed Hearing Professionals and Leading Salespeople from Competitor PlatformsAims to Enhance Customer Experience and Deliver Revenue Growth ROSEVILLE,...
Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
April 02, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
XYMOGEN Launches Pharmaceutix(TM) Medical Foods Division and Partners With Acasti Pharma to Bring Revolutionary Medical Food to United States and Beyond
July 11, 2012 08:37 ET
|
XYMOGEN
ORLANDO, Fla., July 11, 2012 (GLOBE NEWSWIRE) -- XYMOGEN announced today an exclusive partnership with Acasti Pharma, the biopharmaceutical company with whom they will launch the worldwide...
H. Lundbeck and Pharmexa Achieve Important Milestone in Research Collaboration
December 10, 2002 10:48 ET
|
Pharmexa A/S
HORSHOLM, Denmark, Dec. 10, 2002 (PRIMEZONE) -- Pharmexa (Other OTC:PMXAY) today announced important progress in a research collaboration with H. Lundbeck established in April 2000. The focus of the...
Ortivus: Interim Report, January - September 2002
October 28, 2002 08:05 ET
|
Ortivus
STOCKHOLM, Sweden, Oct. 28, 2002 (PRIMEZONE) -- Ortivus AB (publ) (Other OTC:ORIVF) (Stockholm:ORTIa):
Significant events during the period:
- Sales were up 19 percent to MSEK 125.9 (105.8...
Cardio Control Q3: Sales Doubled, Record Earnings Expected for 2002
October 15, 2002 09:45 ET
|
Cardio Control NV
DELFT, The Netherlands, Oct. 15, 2002 (PRIMEZONE) -- Cardio Control NV has doubled its sales in the 3rd quarter compared with the same quarter last year. Sales amounted to EUR 2,4 mln compared to EUR...
Getinge: Interim Report, June 2002
July 15, 2002 02:39 ET
|
Getinge
STOCKHOLM, Sweden, July 15, 2002 (PRIMEZONE) -- Getinge:
-- Heraeus acquisition concluded during Q2 - significant synergy effects
-- The Q2 profit before tax rose by 22%
-- The profit before tax...
CardioDynamics: Study on BioZ ICG Validates Noninvasive Technology as Equivalent to Pulmonary Artery Catheter
March 12, 2002 07:00 ET
|
CardioDynamics International Corporation
SAN DIEGO, March 12, 2002 (PRIMEZONE) -- CardioDynamics (Nasdaq:CDIC), the innovator and global leader of Impedance Cardiography (ICG) technology, today announced that a significant ICG study was...
Women First HealthCare to Announce 4th Quarter and Year-End 2001 Results on February 13, 2002
February 11, 2002 07:02 ET
|
Women First HealthCare, Inc.
SAN DIEGO, Feb. 11, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) said that on Wednesday, February 13, 2002 the Company will release its financial results for the fourth quarter and...